Finextra and Cloudera Report Reveals Hybrid AI is the New Standard in Financial Services, with 91% Citing It as Highly Valuable Crinetics Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Reported positive topline results for the ACROBAT Edge and Evolve Phase 2 trials of oral…
Atreca to Present at Upcoming Virtual Investor Conferences
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL),…
Atea Pharmaceuticals Expands Board of Directors with Appointment of Barbara Duncan
Experienced Financial Executive Brings Leadership and Public Company Expertise BOSTON, Nov. 06, 2020 (GLOBE NEWSWIRE)…
Bio-Path Holdings to Announce Third Quarter 2020 Financial Results on November 13, 2020
HOUSTON, Nov. 06, 2020 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company…
Shattuck Labs to Present Virtually at Cowen 4th Annual IO Next Summit
AUSTIN, TX and DURHAM, NC, Nov. 06, 2020 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck)…
Vir Biotechnology Publishes New Research Characterizing Variation in the SARS-CoV-2 Spike Protein and Virulence of a Prevalent Immune Evasion Variant, N439K
– Manuscript highlights the importance of molecular surveillance of SARS-CoV-2 immune evasion and rational design…
Cocrystal Pharma to Present at the H.C. Wainwright 6th Annual Israel Conference
– Live video webcast with the Cocrystal management team, on Thursday, November 12th at 12:00…
Novo Nordisk to Acquire Emisphere Technologies for $1.35 Billion
ROSELAND, N.J., Nov. 06, 2020 (GLOBE NEWSWIRE) — Emisphere Technologies, Inc. (“Emisphere” or the “Company”)…
Invitation to Active Biotech’s virtual capital markets day
Active Biotech AB (publ) (ticker: ACTI) hereby invites analysts, investors and media to its virtual…
Ocugen Provides Business Update and Third Quarter 2020 Financial Results
First Gene Therapy Candidate OCU400 On Track to Enter the Clinic in 2021 MALVERN, Pa.,…
Progenity Announces Encouraging Preclinical Data Supporting the Potential of the Company’s Oral Drug Delivery System in Targeting the Colon
SAN DIEGO, Nov. 06, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company…
Aleafia Health Successful Outdoor Harvest Accelerates Product Portfolio Expansion
Aleafia Health Port Perry Outdoor cannabis cultivation. TORONTO, Nov. 06, 2020 (GLOBE NEWSWIRE) — Aleafia…
Apollomics, Inc. Closes $124 Million Series C Financing
– Financing led by Ping An Capital – – Phase 2 SPARTA Trial for APL-101…
Matinas BioPharma Reports Third Quarter 2020 Financial Results and Operational Highlights
EnACT study of MAT2203 in cryptococcal meningitis received unanimous Data and Safety Monitoring Board (DSMB)…
FibroGen to Present at Upcoming Investor Conferences
SAN FRANCISCO, Nov. 06, 2020 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) today announced that…
Jounce Therapeutics Reports Third Quarter 2020 Financial Results
-On track to begin enrollment in the Phase 1 trial for JTX-8064 by year-end 2020-…
Adicet Bio to Participate in Upcoming Investor Conferences
MENLO PARK, Calif. and BOSTON, Nov. 06, 2020 (GLOBE NEWSWIRE) — Adicet Bio, Inc. (Nasdaq:…
Industry Veteran Susan Benton Joins the Ocuphire Pharma Board of Directors
FARMINGTON HILLS, Mich., Nov. 06, 2020 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc., a clinical-stage ophthalmic…
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2020
Reports Net Revenues of $83.4 Million for the Three Months Ended September 30, 2020 RANCHO…
Assertio Reports Third Quarter 2020 Financial Results
Reported Net Product Sales of $34.3 Million Non-GAAP Net Product Sales of $33.7 Million; Increased…